Bristol-Myers Squibb Company (BMY)

61.33
NYSE
Prev Close 62.10
Day Low/High 61.26 / 62.70
52 Wk Low/High 45.76 / 67.16
Exchange NYSE
Shares Outstanding 2240.47B
Market Cap 139.13B
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Jim Cramer: Looking for Gold? Go With Science

Jim Cramer: Looking for Gold? Go With Science

A potential breakthrough in Alzheimer's. A new device for blood pressure. More vaccines. These are opportunities to cheer in a time of turmoil.

Bristol-Myers Squibb Could Finally Make Its Move

Bristol-Myers Squibb Could Finally Make Its Move

Traders should stay long and consider increasing their exposure.

How to Play Emergent BioSolutions Right Now

How to Play Emergent BioSolutions Right Now

A correction in EBS could soon set up an attractive opportunity.

The Week That Was, Q4 Earnings Expectations, Key Investor and Healthcare Events

The Week That Was, Q4 Earnings Expectations, Key Investor and Healthcare Events

This Friday several banks begin the unofficial kickoff of 'earnings season'.

How I'm Playing Astra-Zeneca on Vaccine and Acquisition News

How I'm Playing Astra-Zeneca on Vaccine and Acquisition News

I am staying away from this name for now, despite the Alexion acquisition and vaccine promise.

2 Potential Acquisition Targets as Biotech Deal Activity Picks Up

2 Potential Acquisition Targets as Biotech Deal Activity Picks Up

BioXcel Therapeutics and Avadel Pharmaceuticals would make good additions to the portfolios of larger drug companies.

This Trio of Diverse Stocks Makes for Interesting Stalking

This Trio of Diverse Stocks Makes for Interesting Stalking

The technical patterns of Boeing, Bristol-Myers Squibb and DraftKings are worth tracking for potential buys.

Eli Lilly: Back From the Depths

Eli Lilly: Back From the Depths

I am flat LLY for now. Let's see how the shares behave around the technicals. Then we'll make an equity decision.

Election Hindsight, Treasury Yields, Fed Day, Chip Stock Setup, A Great Trade

Election Hindsight, Treasury Yields, Fed Day, Chip Stock Setup, A Great Trade

The most important market takeaway right now is that both the Nasdaq Composite and S&P 500 have filled their respective gaps and retaken their 50-day simple moving averages.

Jim Cramer: Let's Bust These Election Myths

Jim Cramer: Let's Bust These Election Myths

These are the top five misconceptions about presidential elections -- and the stocks that you should look at right now.

Jim Cramer: Here's Why the President Is Gambling With Stimulus

Jim Cramer: Here's Why the President Is Gambling With Stimulus

The market is reflecting a triumph of big business over small business, and here's what that means for individual stocks.

Bristol-Myers Squibb Could Soon Break Out of a Large Triangle Pattern

Bristol-Myers Squibb Could Soon Break Out of a Large Triangle Pattern

Aggressive traders could go long BMY at two price levels.

Trump's Health and the Market, Charts That Matter, Nvidia News, URI Breaks Out

Trump's Health and the Market, Charts That Matter, Nvidia News, URI Breaks Out

Even more important than fiscal support moving forward would be the concept of Covid-19 very soon being effectively treatable for the public.

Jim Cramer: Does Everyone Out There Perceive That Everything Is a Win?

Jim Cramer: Does Everyone Out There Perceive That Everything Is a Win?

It's remarkable to see such excitement based on totally contradictory theories and themes.

Does 'Aggressive' Bristol-Myers Have the Right Prescription for Investors?

Does 'Aggressive' Bristol-Myers Have the Right Prescription for Investors?

BMY's announced acquisition of MyoKardia for $13B comes less than a year after its purchase of Celgene.

Jim Cramer: Diversification Is the Key to Getting Through This Market Upheaval

Jim Cramer: Diversification Is the Key to Getting Through This Market Upheaval

This diversification strategy lets you to capture stock market upside, while not risking your shirt.

A Healthy Dose of Vaccine and Pharmaceutical Plays

A Healthy Dose of Vaccine and Pharmaceutical Plays

6 favorite stocks and ETFs in the biotech and pharmaceutical sector, including a diversified basket of Covid-19 vaccine names.

Elections and Stocks: Party Performance, Predicting and Potential Market Winners

Elections and Stocks: Party Performance, Predicting and Potential Market Winners

The market's performance in the three months leading up to a presidential election has displayed an uncanny ability to forecast which party will win the White House.

Back to Back Wins for Bristol-Myers, and Here's How I'd Trade It

Back to Back Wins for Bristol-Myers, and Here's How I'd Trade It

BMY sees reason for optimism over the final half of the year.

Charting the Dow, Job Creation, Washington Deal or No Deal? Roku's Problem

Charting the Dow, Job Creation, Washington Deal or No Deal? Roku's Problem

Check out the Dow Transports and the Dow Industrials.

7 Drug Stocks With the Right Medicine for Investors

7 Drug Stocks With the Right Medicine for Investors

These pharmaceutical favorites continue to make progress on a number of fronts including a Covid-19 vaccine.

Use DRIPs to Build a Socially Responsible Portfolio

Use DRIPs to Build a Socially Responsible Portfolio

Many quality companies that fit into the socially responsible investing camp offer direct-purchase plans, allowing investors an easy way to build an SRI portfolio.

SPACs Aren't Just for Trading: 2 Attractive Buy and Hold Opportunities

SPACs Aren't Just for Trading: 2 Attractive Buy and Hold Opportunities

I like putting some of my money with incredibly successful folks who are well-connected and have a history of success.

This Chart Pattern Hints at a Bullish Future

This Chart Pattern Hints at a Bullish Future

The bullish reversal pattern is appearing not just in single names, but also in whole sectors.

Trading Volume, Late Selloffs, Peloton's Run Higher

Trading Volume, Late Selloffs, Peloton's Run Higher

As Treasury heads for longer-dated issuance and names like PTON run higher on earnings, selloffs late in the trading day continue.

Genprex Is Soaring - And There's a One Word Reason Why

Genprex Is Soaring - And There's a One Word Reason Why

The small biotech's market cap sits at $125 million, the low end of what I believe is fair.